Skip to content
Screener

Delcath Systems DCTH Net debt / EBITDA

Net debt / EBITDA at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
1.1×-0.5×
Boston Scientific logo
Boston ScientificBSX
-0.1×-2.9×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-116.1×—
Gilead Sciences logo
Gilead SciencesGILD
1.4×-0.6×

Other financials

Income statement

See full
Revenue$29.1M+20.6%
Gross profit$26.1M+25.5%
Operating income$2.4M-7.5%
Net income$2.7M-1.1%
EPS (diluted)$0.070.0%

Balance sheet

See full
Cash & equivalents$47.5M+38.0%
Total debt$2.5M+148%
Total equity$121.1M+15.4%
Total assets$137.0M+17.2%

Cash flow

See full
Operating cash flow$5.7M-21.7%
CapEx$503.0K+26.4%
Free cash flow$5.2M-24.5%

Valuation

See full
Market cap$534.05M+44.1%
Enterprise value$489.01M+45.0%
P/E104.2×—
P/S5.6×+0.3×

Profitability

See full
Gross margin87.1%+1.2pp
Operating margin-118.1%-56.8pp
Net margin1.5%+0.8pp
FCF margin18.3%+12.8pp

Returns & leverage

See full
Return on equity1.9%+1.0pp
Debt / equity0×0.0×
Current ratio9.8×-1.0×

Where this comes from

Calculated from Delcath Systems’s reported figures.

net debt/ebitda=-1,856.2×

Based on the most recent quarter.

The source filing: Delcath Systems’s 10-Q, filed November 4, 2025. Open the filing →

Filed
Nov 4, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001628280-25-048558

FAQ

What is Delcath Systems's net debt / EBITDA?
Delcath Systems (DCTH) reported net debt / EBITDA of -1,856.2× in Q3 2025.
What does net debt / EBITDA mean?
Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Ask your AI about Delcath Systems's net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude